BIG PHARMAS, NOT SUCH AN ALL-WEATHER INVESTMENT
25/06/20 -"This story was first issued on 15-06-2020. ‘Valuation Wise’ takes a rest. Pre-COVID-19, holding Big Pharmas (seven issuers, €940bn market cap) would not make a big difference ..."
Pages
72
Language
English
Published on
25/06/20
You may also be interested by these reports :
23/12/25
Hope for the best has come to define 2025. The worst never showed up and we at AlphaValue were wrong to prepare for it. The vanity of Trump moves, ...
16/12/25
We apologise for the potentially politically incorrect nature of our analysis, but we view the EU’s plan to use Russian assets less as direct ...
12/12/25
In our previous paper on Swedbank (REDUCE ; Sweden) in July 2024, we viewed Swedbank as essentially a value play in the Swedish banks pack, as the ...
04/12/25
We have upgraded our EPS projections on Swedbank with the bulk of the upgrade occurring in 2025 (+20%), as our estimates were overly conservative for ...